You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股》撥康視雲(02592.HK)公開發售獲78.78倍認購 一手中籤率5%
撥康視雲-B(02592.HK)公布招股結果,香港公開發售接獲78.78倍認購,一手(500股)中籤率5%,認購2.5萬股獲穩派一手。國際發售錄得0.89倍認購。經重新分配,公開發售股份增加至1,211.55萬股,佔發售總數20%。股份預期周四(3日)上市。 臨床階段眼科生物科技公司撥康視雲-B是次擬全球發售6,058.2萬股,公開發售原佔10%。發售價10.1元,集資淨額5.22億元。兩名基石投資者中源協和細胞基因工程董事長龔虹嘉旗下的富策控股,以及投資機構The Reynold Lemkins合共購入1,772萬股。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account